Findings from the Coronavirus (COVID-19) Infection Survey for England.

The number of deaths registered in England and Wales due to and involving coronavirus (COVID-19). Breakdowns include age, sex, region, local authority, Middle-layer Super Output Area (MSOA), indices of deprivation and place of death. Includes age-specific and age-standardised mortality rates.

United Kingdom recorded 24603076 Coronavirus Cases since the epidemic began, according to the World Health Organization (WHO). In addition, United Kingdom reported 225324 Coronavirus Deaths. This dataset includes a chart with historical data for the United Kingdom Coronavirus Cases.

Headline estimates for England, Wales, Northern Ireland and Scotland. 

The purpose of this dataset is to understand the prevalence of the coronavirus in the UK population, using longitudinal data and including not only cross-sectional data but the inclusion of an antibody test for a sub-sample of people. Demographic information is also included allowing for analyse by different variables to identify patterns and trends.

Participants have three options open to them; can have just have one visit, can have a visit every week for a month or, can have a visit every week for a month and then continue to have visits every month for one year in total from when you joined the study. This is entirely voluntary.

At each visit a field worker conducts a questionnaire, and supervises swab tests. A proportion of visits also include a blood sample being taken. The swab and blood samples are tested at laboratories.

The overall purpose of this study is to understand how many people across the UK have or may already have had the coronavirus. This will help the government manage the pandemic moving forwards.

The COVID-19 Community Infection Survey includes information on: • how many people across England and Wales (extending to Scotland and Northern Ireland) test positive for COVID-19 at a given point in time, regardless of whether they report experiencing symptoms • the average number of new infections per week over the course of the study • the number of people who test positive for antibodies, to indicate how many people are ever likely to have had the virus • key demographic information (sex, age, occupation)

The COVID-19 Health Inequalities Monitoring in England (CHIME) tool brings together data relating to the direct impacts of coronavirus (COVID-19) on factors such as mortality rates, hospital admissions, confirmed cases and vaccinations.

By presenting inequality breakdowns - including by age, sex, ethnic group, level of deprivation and region - the tool provides a single point of access to:

• show how inequalities have changed during the course of the pandemic and what the current cumulative picture is
• bring together data in one tool to enable users to access and use the intelligence more easily
• provide indicators with a consistent methodology across different data sets to facilitate understanding
• support users to identify and address inequalities within their areas, and identify priority areas for recovery

In the March 2023 update, data has been updated for deaths, hospital admissions and vaccinations. Data on inequalities in vaccination uptake within upper tier local authorities has been added to the tool for the first time. This replaces data for lower tier local authorities, published in December 2022, allowing the reporting of a wider range of inequality breakdowns within these areas.

Please send any questions or comments to PHA-OHID@dhsc.gov.uk

Age-standardised mortality rates (ASMRs) for deaths involving COVID-19 by ethnic group, England.

Due to changes in the collection and availability of data on COVID-19, this dataset is no longer updated. Latest information about COVID-19 is available via the UKHSA data dashboard. The UK government publish daily data, updated weekly, on COVID-19 cases, vaccinations, hospital admissions and deaths. This note provides a summary of the key data for London from this release. Data are published through the UK Coronavirus Dashboard, last updated on 23 March 2023. This update contains: Data on the number of cases identified daily through Pillar 1 and Pillar 2 testing at the national, regional and local authority level Data on the number of people who have been vaccinated against COVID-19 Data on the number of COVID-19 patients in Hospital Data on the number of people who have died within 28 days of a COVID-19 diagnosis Data for London and London boroughs and data disaggregated by age group Data on weekly deaths related to COVID-19, published by the Office for National Statistics and NHS, is also available. Key Points On 23 March 2023 the daily number of people tested positive for COVID-19 in London was reported as 2,775 On 23 March 2023 it was newly reported that 94 people in London died within 28 days of a positive COVID-19 test The total number of COVID-19 cases identified in London to date is 3,146,752 comprising 15.2 percent of the England total of 20,714,868 cases In the most recent week of complete data (12 March 2023 - 18 March 2023) 2,951 new cases were identified in London, a rate of 33 cases per 100,000 population. This compares with 2,883 cases and a rate of 32 for the previous week In England as a whole, 29,426 new cases were identified in the most recent week of data, a rate of 52 cases per 100,000 population. This compares with 26,368 cases and a rate of 47 for the previous week Up to and including 22 March 2023 6,452,895 people in London had received the first dose of a COVID-19 vaccine and 6,068,578 had received two doses Up to and including 22 March 2023 4,435,586 people in London had received either a third vaccine dose or a booster dose On 22 March 2023 there were 1,370 COVID-19 patients in London hospitals. This compares with 1,426 patients on 15 March 2023. On 22 March 2023 there were 70 COVID-19 patients in mechanical ventilation beds in London hospitals. This compares with 72 patients on 15 March 2023. Update: From 1st July updates are weekly From Friday 1 July 2022, this page will be updated weekly rather than daily. This change results from a change to the UK government COVID-19 Dashboard which will move to weekly reporting. Weekly updates will be published every Thursday. Daily data up to the most recent available will continue to be added in each weekly update. Data summary 리소스 CSV phe_vaccines_age_london_boroughs.csv CSV 다운로드 phe_vaccines_age_london_boroughs.csv CSV phe_healthcare_admissions_age.csv CSV 다운로드

This file contains the digital vector boundaries for Covid Infection Survey Geography, in the United Kingdom, as at December 2020.The boundaries available are: (BFE) Full resolution - extent of the realm (usually this is the Mean Low Water mark but in some cases boundaries extend beyond this to include off shore islands).Contains both Ordnance Survey and ONS Intellectual Property Rights.

REST URL of Feature Access Service – https://services1.arcgis.com/ESMARspQHYMw9BZ9/arcgis/rest/services/Covid_Infection_Survey_Dec_2020_UK_BFE/FeatureServerREST URL of WFS Server –https://dservices1.arcgis.com/ESMARspQHYMw9BZ9/arcgis/services/Covid_Infection_Survey_Dec_2020_UK_BFE/WFSServer?service=wfs&request=getcapabilitiesREST URL of Map Server –https://services1.arcgis.com/ESMARspQHYMw9BZ9/arcgis/rest/services/Covid_Infection_Survey_Dec_2020_UK_BFE/MapServer

Experimental estimates of the prevalence and duration of long COVID symptoms, and rates of adverse events for hospitalised coronavirus (COVID-19) patients compared with those for matched control patients.

The Public Health Research Database (PHRD) is a linked asset which currently includes Census 2011 data; Mortality Data; Hospital Episode Statistics (HES); GP Extraction Service (GPES) Data for Pandemic Planning and Research data. Researchers may apply for these datasets individually or any combination of the current 4 datasets.

The purpose of this dataset is to enable analysis of deaths involving COVID-19 by multiple factors such as ethnicity, religion, disability and known comorbidities as well as age, sex, socioeconomic and marital status at subnational levels. 2011 Census data for usual residents of England and Wales, who were not known to have died by 1 January 2020, linked to death registrations for deaths registered between 1 January 2020 and 8 March 2021 on NHS number. The data exclude individuals who entered the UK in the year before the Census took place (due to their high propensity to have left the UK prior to the study period), and those over 100 years of age at the time of the Census, even if their death was not linked. The dataset contains all individuals who died (any cause) during the study period, and a 5% simple random sample of those still alive at the end of the study period. For usual residents of England, the dataset also contains comorbidity flags derived from linked Hospital Episode Statistics data from April 2017 to December 2019 and GP Extraction Service Data from 2015-2019.

As the UK went into the first lockdown of the COVID-19 pandemic, the team behind the biggest social survey in the UK, Understanding Society (UKHLS), developed a way to capture these experiences. From April 2020, participants from this Study were asked to take part in the Understanding Society COVID-19 survey, henceforth referred to as the COVID-19 survey or the COVID-19 study.

The COVID-19 survey regularly asked people about their situation and experiences. The resulting data gives a unique insight into the impact of the pandemic on individuals, families, and communities. The COVID-19 Teaching Dataset contains data from the main COVID-19 survey in a simplified form. It covers topics such as

• Socio-demographics
• Whether working at home and home-schooling
• COVID symptoms
• Health and well-being
• Social contact and neighbourhood cohesion
• Volunteering

The resource contains two data files:

• Cross-sectional: contains data collected in Wave 4 in July 2020 (with some additional variables from other waves);
• Longitudinal: Contains mainly data from Waves 1, 4 and 9 with key variables measured at three time points.

Key features of the dataset

• Missing values: in the web survey, participants clicking "Next" but not answering a question were given further options such as "Don't know" and "Prefer not to say". Missing observations like these are recorded using negative values such as -1 for "Don't know". In many instances, users of the data will need to set these values as missing. The User Guide includes Stata and SPSS code for setting negative missing values to system missing.

• The Longitudinal file is a balanced panel and is in wide format. A balanced panel means it only includes participants that took part in every wave. In wide format, each participant has one row of information, and each measurement of the same variable is a different variable.

• Weights: both the cross-sectional and longitudinal files include survey weights that adjust the sample to represent the UK adult population. The cross-sectional weight (betaindin_xw) adjusts for unequal selection probabilities in the sample design and for non-response. The longitudinal weight (ci_betaindin_lw) adjusts for the sample design and also for the fact that not all those invited to participate in the survey, do participate in all waves.

• Both the cross-sectional and longitudinal datasets include the survey design variables (psu and strata).

A full list of variables in both files can be found in the User Guide appendix.

Who is in the sample?

All adults (16 years old and over as of April 2020), in households who had participated in at least one of the last two waves of the main study Understanding Society, were invited to participate in this survey. From the September 2020 (Wave 5) survey onwards, only sample members who had completed at least one partial interview in any of the first four web surveys were invited to participate. From the November 2020 (Wave 6) survey onwards, those who had only completed the initial survey in April 2020 and none since, were no longer invited to participate

The User guide accompanying the data adds to the information here and includes a full variable list with details of measurement levels and links to the relevant questionnaire.

As of May 2, 2023, there were roughly 687 million global cases of COVID-19. Around 660 million people had recovered from the disease, while there had been almost 6.87 million deaths. The United States, India, and Brazil have been among the countries hardest hit by the pandemic.

The various types of human coronavirus The SARS-CoV-2 virus is the seventh known coronavirus to infect humans. Its emergence makes it the third in recent years to cause widespread infectious disease following the viruses responsible for SARS and MERS. A continual problem is that viruses naturally mutate as they attempt to survive. Notable new variants of SARS-CoV-2 were first identified in the UK, South Africa, and Brazil. Variants are of particular interest because they are associated with increased transmission.

Vaccination campaigns Common human coronaviruses typically cause mild symptoms such as a cough or a cold, but the novel coronavirus SARS-CoV-2 has led to more severe respiratory illnesses and deaths worldwide. Several COVID-19 vaccines have now been approved and are being used around the world.

Estimates of the risk of hospital admission for coronavirus (COVID-19) and death involving COVID-19 by vaccination status, overall and by age group, using anonymised linked data from Census 2021. Experimental Statistics.

Outcome definitions

For this analysis, we define a death as involving COVID-19 if either of the ICD-10 codes U07.1 (COVID-19, virus identified) or U07.2 (COVID-19, virus not identified) is mentioned on the death certificate. Information on cause of death coding is available in the User Guide to Mortality Statistics. We use date of occurrance rather than date of registration to give the date of the death.

We define COVID-109 hospitalisation as an inpatient episode in Hospital Episode Statistics where the primary diagnosis was COVID-19, identified by the ICD-19 codes (COVID-19, virus identified) or U07.2 (COVID-19, virus not identified). Where an individual had experienced more than one COVID-19 hospitalisation, the earliest that occurred within the study period was used. We define the date of COVID-19 hospitalisation as the start of the hospital episode.

ICD-10 code

U07.1 :

COVID-19, virus identified

U07.2:

COVID-19, virus not identified

Vaccination status is defined by the dose and the time since the last dose received

Unvaccinated:

no vaccination to less than 21 days post first dose

First dose 21 days to 3 months:

more than or equal to 21 days post second dose to earliest of less than 91 days post first dose or less than 21 days post second dose

First dose 3+ months:

more than or equal to 91 days post first dose to less than 21 days post second dose

Second dose 21 days to 3 months:

more than or equal to 21 days post second dose to earliest of less than 91 days post second dose or less than 21 days post third dose

Second dose 3-6 months:

more than or equal to 91 days post second dose to earliest of less than 182 days post second dose or less than 21 days post third dose

Second dose 6+ months:

more than or equal to 182 days post second dose to less than 21 days post third dose

Third dose 21 days to 3 months:

more than or equal to 21 days post third dose to less than 91 days post third dose

Third dose 3+ months:

more than or equal to 91 days post third dose

Model adjustments

Three sets of model adjustments were used

Age adjusted:

age (as a natural spline)

Age, socio-demographics adjusted:

age (as a natural spline), plus socio-demographic characteristics (sex, region, ethnicity, religion, IMD decile, NSSEC category, highest qualification, English language proficiency, key worker status)

Fully adjusted:

age (as a natural spline), plus socio-demographic characteristics (sex, region, ethnicity, religion, IMD decile, NSSEC category, highest qualification, English language proficiency, key worker status), plus health-related characteristics (disability, self-reported health, care home residency, number of QCovid comorbidities (grouped), BMI category, frailty flag and hospitalisation within the last 21 days.

Age

Age in years is defined on the Census day 2021 (21 March 2021). Age is included in the model as a natural spline with boundary knots at the 10th and 90th centiles and internal knots at the 25th, 50th and 75th centiles. The positions of the knots are calculated separately for the overall model and for each age group for the stratified model.

The dataset contains a daily situation update on COVID-19, the epidemiological curve and the global geographical distribution (EU/EEA and the UK, worldwide).

On 12 February 2020, the novel coronavirus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) while the disease associated with it is now referred to as COVID-19. Since the beginning of the coronavirus pandemic, ECDC’s Epidemic Intelligence team has been collecting on daily basis the number of COVID-19 cases and deaths, based on reports from health authorities worldwide. To insure the accuracy and reliability of the data, this process is being constantly refined. This helps to monitor and interpret the dynamics of the COVID-19 pandemic not only in the European Union (EU), the European Economic Area (EEA), but also worldwide. Every day between 6.00 and 10.00 CET, a team of epidemiologists screens up to 500 relevant sources to collect the latest figures. The data screening is followed by ECDC’s standard epidemic intelligence process for which every single data entry is validated and documented in an ECDC database. An extract of this database, complete with up-to-date figures and data visualisations, is then shared on the ECDC website, ensuring a maximum level of transparency.

ECDC switched to a weekly reporting schedule for the COVID-19 situation worldwide and in the EU/EEA and the UK on 17 December 2020. Hence, all daily updates have been discontinued from 14 December. The weekly data can be found in the dataset COVID-19 Coronavirus data - weekly (from 17 December 2020).

If you reuse or enrich this dataset, please share it with us.

This file contains the digital vector boundaries for Covid Infection Survey Geography, in the United Kingdom, as at December 2020.The boundaries available are: (BFC) Full resolution - clipped to the coastline (Mean High Water mark).Contains both Ordnance Survey and ONS Intellectual Property Rights.

REST URL of Feature Access Service – https://services1.arcgis.com/ESMARspQHYMw9BZ9/arcgis/rest/services/Covid_Infection_Survey_Dec_2020_UK_BFC/FeatureServerREST URL of WFS Server –https://dservices1.arcgis.com/ESMARspQHYMw9BZ9/arcgis/services/Covid_Infection_Survey_Dec_2020_UK_BFC/WFSServer?service=wfs&request=getcapabilitiesREST URL of Map Server –https://services1.arcgis.com/ESMARspQHYMw9BZ9/arcgis/rest/services/Covid_Infection_Survey_Dec_2020_UK_BFC/MapServer

A lookup file between 2011 Middle Layer Super Output Areas (MSOA) to 2020 Covid Infection Survey Geography in the United Kingdom, as at 1 October 2020. (File size - 920KB) Field Names - MSOA11CD, MSOA11NM, MSOA11NMW, CIS20CD, FIDField Types - Text, Text, Text, Text, NumericField Lengths - 9, 255, 255, 9FID = The FID, or Feature ID is created by the publication process when the names and codes / lookup products are published to the Open Geography portal. REST URL of Feature Access Service – https://services1.arcgis.com/ESMARspQHYMw9BZ9/arcgis/rest/services/MSOA11_to_CIS20_Lookup_131d08fc16814c5d8113175e0c9c6de2/FeatureServer